Fetal death in utero and miscarriage in a patient with Crohn's disease under therapy with ustekinumab: case-report and review of the literature.
about
Ustekinumab use in Crohn's disease: a Canadian tertiary care centre experience.Ustekinumab drug levels in maternal and cord blood in a woman with Crohn's disease treated until 33 weeks gestation.Interleukin 12/interleukin 23 pathway: Biological basis and therapeutic effect in patients with Crohn's disease
P2860
Fetal death in utero and miscarriage in a patient with Crohn's disease under therapy with ustekinumab: case-report and review of the literature.
description
2017 nî lūn-bûn
@nan
2017 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Fetal death in utero and misca ...... and review of the literature.
@ast
Fetal death in utero and misca ...... and review of the literature.
@en
type
label
Fetal death in utero and misca ...... and review of the literature.
@ast
Fetal death in utero and misca ...... and review of the literature.
@en
prefLabel
Fetal death in utero and misca ...... and review of the literature.
@ast
Fetal death in utero and misca ...... and review of the literature.
@en
P2093
P2860
P31
P50
P921
P1433
P1476
Fetal death in utero and misca ...... and review of the literature.
@en
P2093
P2860
P2888
P356
10.1186/S12876-017-0633-6
P5008
P577
2017-06-19T00:00:00Z
P6179
1086100180